Percutaneous thoracic duct embolization for persistent chylothorax after fontan operation: Case report
Main Article Content
Abstract
Management of chylothorax can be challenging in Fontan postoperative treatment, especially in persistent chylothorax. The complications of chylothorax are associated with a significantly longer hospitalization stay, increased risk of in-hospital mortality and higher cost of hospitalization. We report a case at the Cardiovascular Center - E hospital. A 3-year-old male presented with persistent chylothorax was successfully performed lymphangiography and percutaneous thoracic duct embolization. This minimally invasive and safe technique will be performed routinally at our center.
Article Details
Keywords
chylothorax, Fontan, children.
References
1. Zuluaga M. Chylothorax after surgery for congenital heart disease. Curr Opin Pediatr. 2012;24:291-294. doi:10.1097/MOP.0b013e3283534b7f
2. Milonakis M, Chatzis AC, Giannopoulos NM, et al. Etiology and management of chylothorax following pediatric heart surgery. J Card Surg. 2009;24(4):369-373. doi:10.1111/j.1540-8191.2008.00781.x
3. Mery CM, Moffett BS, Khan MS, et al. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg. 2014;147(2):678-686.e1; discussion 685-686. doi:10.1016/j.jtcvs.2013.09.068
4. Lo Rito M, Al-Radi OO, Saedi A, et al. Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion. J Thorac Cardiovasc Surg. 2018;155(5):2069-2077. doi:10.1016/j.jtcvs.2017.11.046
5. Savla JJ, Itkin M, Rossano JW, Dori Y. Post-Operative Chylothorax in Patients With Congenital Heart Disease. J Am Coll Cardiol. 2017;69(19):2410-2422. doi:10.1016/j.jacc.2017.03.021
6. McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med. 2010;104(1):1-8. doi:10.1016/j.rmed.2009.08.010
7. Lê Minh Khôi, Nguyễn Hoàng Định, Trương Quang Bình. Tuần hoàn Fontan sau nửa thế kỷ. Tạp Chí Phẫu Thuật Tim Mạch Và Lồng Ngực Việt Nam. 2018;19:37-50. doi:10.47972/vjcts.v19i.106
8. Kelly B, Mohanakumar S, Hjortdal VE. Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease. Curr Cardiol Rep. 2020;22(12):164. doi:10.1007/s11886-020-01405-y
9. Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C. Etiology and management of pediatric chylothorax. J Pediatr. 2000;136(5):653-658. doi:10.1067/mpd.2000.104287
10. Yeh J, Brown ER, Kellogg KA, et al. Utility of a Clinical Practice Guideline in Treatment of Chylothorax in the Post-Operative Congenital Heart Patient. Ann Thorac Surg. 2013;96(3). doi:10.1016/j.athoracsur.2013.05.058
11. Luangrath MA, Pinchot J, Lamers LJ. Case report description of a collaborative approach to thoracic duct embolization in patients with congenital heart disease. J Congenit Cardiol. 2018;2(1):2. doi:10.1186/s40949-018-0016-z
12. Chen E, Itkin M. Thoracic duct embolization for chylous leaks. Semin Interv Radiol. 2011;28(1):63-74. doi:10.1055/s-0031-1273941
13. Laslett D, Trerotola SO, Itkin M. Delayed Complications following Technically Successful Thoracic Duct Embolization. J Vasc Interv Radiol. 2012;23(1):76-79. doi:10.1016/j.jvir.2011.10.008
2. Milonakis M, Chatzis AC, Giannopoulos NM, et al. Etiology and management of chylothorax following pediatric heart surgery. J Card Surg. 2009;24(4):369-373. doi:10.1111/j.1540-8191.2008.00781.x
3. Mery CM, Moffett BS, Khan MS, et al. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg. 2014;147(2):678-686.e1; discussion 685-686. doi:10.1016/j.jtcvs.2013.09.068
4. Lo Rito M, Al-Radi OO, Saedi A, et al. Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion. J Thorac Cardiovasc Surg. 2018;155(5):2069-2077. doi:10.1016/j.jtcvs.2017.11.046
5. Savla JJ, Itkin M, Rossano JW, Dori Y. Post-Operative Chylothorax in Patients With Congenital Heart Disease. J Am Coll Cardiol. 2017;69(19):2410-2422. doi:10.1016/j.jacc.2017.03.021
6. McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med. 2010;104(1):1-8. doi:10.1016/j.rmed.2009.08.010
7. Lê Minh Khôi, Nguyễn Hoàng Định, Trương Quang Bình. Tuần hoàn Fontan sau nửa thế kỷ. Tạp Chí Phẫu Thuật Tim Mạch Và Lồng Ngực Việt Nam. 2018;19:37-50. doi:10.47972/vjcts.v19i.106
8. Kelly B, Mohanakumar S, Hjortdal VE. Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease. Curr Cardiol Rep. 2020;22(12):164. doi:10.1007/s11886-020-01405-y
9. Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C. Etiology and management of pediatric chylothorax. J Pediatr. 2000;136(5):653-658. doi:10.1067/mpd.2000.104287
10. Yeh J, Brown ER, Kellogg KA, et al. Utility of a Clinical Practice Guideline in Treatment of Chylothorax in the Post-Operative Congenital Heart Patient. Ann Thorac Surg. 2013;96(3). doi:10.1016/j.athoracsur.2013.05.058
11. Luangrath MA, Pinchot J, Lamers LJ. Case report description of a collaborative approach to thoracic duct embolization in patients with congenital heart disease. J Congenit Cardiol. 2018;2(1):2. doi:10.1186/s40949-018-0016-z
12. Chen E, Itkin M. Thoracic duct embolization for chylous leaks. Semin Interv Radiol. 2011;28(1):63-74. doi:10.1055/s-0031-1273941
13. Laslett D, Trerotola SO, Itkin M. Delayed Complications following Technically Successful Thoracic Duct Embolization. J Vasc Interv Radiol. 2012;23(1):76-79. doi:10.1016/j.jvir.2011.10.008